§ Funding Round
Series C funding round for Spero Therapeutics raising $52M in March 2017
Series C funding round for Spero Therapeutics raising $52M in March 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
FPV Fund | — | — |
GVLEAD | Organization | — |
MPM Capital | — | — |
SR One | — | — |
Westlake Village BioPartners | — | — |
| Angel | timothy a. springer | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
The Kraft Group | — | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$155M
Top Valuation
-
Spero Therapeutics raised $52M in a Series C round.
The round was announced on 03/01/17.
The round was led by GV.
